These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 29113983
1. FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes. Chan GC, Divers J, Russell GB, Langefeld CD, Wagenknecht LE, Hsu FC, Xu J, Smith SC, Palmer ND, Hicks PJ, Bowden DW, Register TC, Ma L, Carr JJ, Freedman BI. Diabetes Care; 2018 Jan; 41(1):178-186. PubMed ID: 29113983 [Abstract] [Full Text] [Related]
2. Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus. Freedman BI, Divers J, Russell GB, Palmer ND, Bowden DW, Carr JJ, Wagenknecht LE, Hightower RC, Xu J, Smith SC, Langefeld CD, Hruska KA, Register TC. Am J Nephrol; 2015 Jan; 42(6):391-401. PubMed ID: 26693712 [Abstract] [Full Text] [Related]
3. APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes. Freedman BI, Langefeld CD, Lu L, Palmer ND, Smith SC, Bagwell BM, Hicks PJ, Xu J, Wagenknecht LE, Raffield LM, Register TC, Carr JJ, Bowden DW, Divers J. Kidney Int; 2015 Jan; 87(1):176-81. PubMed ID: 25054777 [Abstract] [Full Text] [Related]
4. APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study. Gutiérrez OM, Irvin MR, Zakai NA, Naik RP, Chaudhary NS, Estrella MM, Limou S, Judd SE, Cushman M, Kopp JB, Winkler CA. Am J Kidney Dis; 2020 Jan; 75(1):54-60. PubMed ID: 31563468 [Abstract] [Full Text] [Related]
5. APOL1 Risk Variants, Incident Proteinuria, and Subsequent eGFR Decline in Blacks with Hypertension-Attributed CKD. Chen TK, Tin A, Peralta CA, Appel LJ, Choi MJ, Lipkowitz MS, Winkler CA, Estrella MM. Clin J Am Soc Nephrol; 2017 Nov 07; 12(11):1771-1777. PubMed ID: 29051146 [Abstract] [Full Text] [Related]
8. Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus. Freedman BI, Sink KM, Hugenschmidt CE, Hughes TM, Williamson JD, Whitlow CT, Palmer ND, Miller ME, Lovato LC, Xu J, Smith SC, Launer LJ, Barzilay JI, Cohen RM, Sullivan MD, Bryan RN, Wagner BC, Bowden DW, Maldjian JA, Divers J, AA-DHS MIND and ACCORD MIND Investigators. Am J Kidney Dis; 2017 Nov 07; 70(5):627-637. PubMed ID: 28648301 [Abstract] [Full Text] [Related]
9. Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American Women. Franceschini N, Kopp JB, Barac A, Martin LW, Li Y, Qian H, Reiner AP, Pollak M, Wallace RB, Rosamond WD, Winkler CA. JAMA Cardiol; 2018 Aug 01; 3(8):712-720. PubMed ID: 29971324 [Abstract] [Full Text] [Related]
10. APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension). Chen TK, Appel LJ, Grams ME, Tin A, Choi MJ, Lipkowitz MS, Winkler CA, Estrella MM. Arterioscler Thromb Vasc Biol; 2017 Sep 01; 37(9):1765-1769. PubMed ID: 28572159 [Abstract] [Full Text] [Related]
11. Association Between APOL1 Genotypes and Risk of Cardiovascular Disease in MESA (Multi-Ethnic Study of Atherosclerosis). Chen TK, Katz R, Estrella MM, Gutierrez OM, Kramer H, Post WS, Shlipak MG, Wassel CL, Peralta CA. J Am Heart Assoc; 2017 Dec 21; 6(12):. PubMed ID: 29269352 [Abstract] [Full Text] [Related]
13. Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK. Tin A, Grams ME, Estrella M, Lipkowitz M, Greene TH, Kao WHL, Li L, Appel LJ. Clin J Am Soc Nephrol; 2016 Aug 08; 11(8):1353-1359. PubMed ID: 27230965 [Abstract] [Full Text] [Related]
14. APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume. Freedman BI, Gadegbeku CA, Bryan RN, Palmer ND, Hicks PJ, Ma L, Rocco MV, Smith SC, Xu J, Whitlow CT, Wagner BC, Langefeld CD, Hawfield AT, Bates JT, Lerner AJ, Raj DS, Sadaghiani MS, Toto RD, Wright JT, Bowden DW, Williamson JD, Sink KM, Maldjian JA, Pajewski NM, Divers J. Kidney Int; 2016 Aug 08; 90(2):440-449. PubMed ID: 27342958 [Abstract] [Full Text] [Related]
15. APOL1 Nephropathy Risk Variants and Incident Cardiovascular Disease Events in Community-Dwelling Black Adults. Gutiérrez OM, Irvin MR, Chaudhary NS, Cushman M, Zakai NA, David VA, Limou S, Pamir N, Reiner AP, Naik RP, Sale MM, Safford MM, Hyacinth HI, Judd SE, Kopp JB, Winkler CA. Circ Genom Precis Med; 2018 Jun 08; 11(6):e002098. PubMed ID: 29899045 [Abstract] [Full Text] [Related]
16. APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease. Ma L, Langefeld CD, Comeau ME, Bonomo JA, Rocco MV, Burkart JM, Divers J, Palmer ND, Hicks PJ, Bowden DW, Lea JP, Krisher JO, Clay MJ, Freedman BI. Kidney Int; 2016 Aug 08; 90(2):389-395. PubMed ID: 27157696 [Abstract] [Full Text] [Related]
17. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Freedman BI, Langefeld CD, Murea M, Ma L, Otvos JD, Turner J, Antinozzi PA, Divers J, Hicks PJ, Bowden DW, Rocco MV, Parks JS. Nephrol Dial Transplant; 2011 Nov 08; 26(11):3805-10. PubMed ID: 21931123 [Abstract] [Full Text] [Related]
19. Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants. Nadkarni GN, Chauhan K, Verghese DA, Parikh CR, Do R, Horowitz CR, Bottinger EP, Coca SG. Kidney Int; 2018 Jun 08; 93(6):1409-1416. PubMed ID: 29685497 [Abstract] [Full Text] [Related]
20. APOL1 nephropathy risk variants do not associate with subclinical atherosclerosis or left ventricular mass in middle-aged black adults. Gutiérrez OM, Limou S, Lin F, Peralta CA, Kramer HJ, Carr JJ, Bibbins-Domingo K, Winkler CA, Lewis CE, Kopp JB. Kidney Int; 2018 Mar 08; 93(3):727-732. PubMed ID: 29042080 [Abstract] [Full Text] [Related] Page: [Next] [New Search]